Virology Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Type (Diagnostic Test, Viral Infection Controlling Techniques, Antiviral Chemotherapy, Interferons); Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Sexually Transmitted Diseases, Urinary Tract Infection, Others); End User (Hospitals, Diagnostic Laboratories, Pharmaceutical and Biotechnological Companies, Research and Academic Institutes); and Geography
Virology is broad segment that studies viruses and help in understanding about the infections, mechanism of viruses on the host cells and others. The understanding of the virology helps in preventing the epidemic of the diseases and designing the treatment for various diseases. The virology also helps in the drug formulation and development.
The virology market is expected to grow due to the rising incidences of the infectious diseases, rising incidences of the sexually transmitted viral infections and growing awareness about the viral infection treatments among others. The market is estimated to have growth opportunities to the rising developments in the diagnostic segment and rising option for the treatments.
The "Global Virology Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of virology market with detailed market segmentation by type, application, end user and geography. The global virology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading virology market players and offers key trends and opportunities in the market.
The global virology market is segmented on the basis of type, application, and end user. Based on the type the market is classified as diagnostic test, viral infection controlling techniques, antiviral chemotherapy, and interferons. Based on application the market is segmented as skin and soft tissue infections, respiratory tract infections, GI tract infections, sexually transmitted diseases, urinary tract infection, and others. and on the basis of end user the market is classified as hospitals, diagnostic laboratories, pharmaceutical & biotechnological companies, research & academic institutes.
Get more information on this report :
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global virology market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The virology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting virology market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the virology market in these regions.
Get more information on this report :
The reports cover key developments in the virology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from virology market are anticipated to lucrative growth opportunities in the future with the rising demand for virology market in the global market. Below mentioned is the list of few companies engaged in the virology market.
The report also includes the profiles of key virology market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Johnson and Johnson Services Inc.
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Boehringer Ingelheim Corporation
Merck and Co. Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION 1.1. SCOPE OF THE STUDY 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 1.3. MARKET SEGMENTATION 1.3.1 Virology Market - By Type 1.3.2 Virology Market - By Application 1.3.3 Virology Market - By End User 1.3.4 Virology Market - By Region 22.214.171.124 By Country 2. KEY TAKEAWAYS 3. RESEARCH METHODOLOGY 4. VIROLOGY MARKET LANDSCAPE 4.1. OVERVIEW 4.2. PEST ANALYSIS 4.2.1 North America - Pest Analysis 4.2.2 Europe - Pest Analysis 4.2.3 Asia-Pacific - Pest Analysis 4.2.4 Middle East and Africa - Pest Analysis 4.2.5 South and Central America - Pest Analysis 4.3. EXPERT OPINIONS 5. VIROLOGY MARKET - KEY MARKET DYNAMICS 5.1. KEY MARKET DRIVERS 5.2. KEY MARKET RESTRAINTS 5.3. KEY MARKET OPPORTUNITIES 5.4. FUTURE TRENDS 5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC 6. VIROLOGY MARKET - GLOBAL MARKET ANALYSIS 6.1. VIROLOGY - GLOBAL MARKET OVERVIEW 6.2. VIROLOGY - GLOBAL MARKET AND FORECAST TO 2027 6.3. MARKET POSITIONING/MARKET SHARE 7. VIROLOGY MARKET - REVENUE AND FORECASTS TO 2027 - TYPE 7.1. OVERVIEW 7.2. TYPE MARKET FORECASTS AND ANALYSIS 7.3. DIAGNOSTIC TEST 7.3.1. Overview 7.3.2. Diagnostic Test Market Forecast and Analysis 7.3.3. DNA Virus Testing Market 126.96.36.199. Overview 188.8.131.52. DNA Virus Testing Market Forecast and Analysis 7.3.4. RNA Virus Testing Market 184.108.40.206. Overview 220.127.116.11. RNA Virus Testing Market Forecast and Analysis 7.3.5. Others Market 18.104.22.168. Overview 22.214.171.124. Others Market Forecast and Analysis 7.4. VIRAL INFECTION CONTROLLING TECHNIQUES 7.4.1. Overview 7.4.2. Viral Infection Controlling Techniques Market Forecast and Analysis 7.4.3. Immunoprophylaxis Market 126.96.36.199. Overview 188.8.131.52. Immunoprophylaxis Market Forecast and Analysis 7.4.4. Active Prophylaxis Market 184.108.40.206. Overview 220.127.116.11. Active Prophylaxis Market Forecast and Analysis 7.4.5. Passive Prophylaxis Market 18.104.22.168. Overview 22.214.171.124. Passive Prophylaxis Market Forecast and Analysis 7.5. ANTIVIRAL CHEMOTHERAPY 7.5.1. Overview 7.5.2. Antiviral Chemotherapy Market Forecast and Analysis 7.5.3. Virucidal Agents Market 126.96.36.199. Overview 188.8.131.52. Virucidal Agents Market Forecast and Analysis 7.5.4. Antiviral Agents Market 184.108.40.206. Overview 220.127.116.11. Antiviral Agents Market Forecast and Analysis 7.5.5. Immunomodulators Market 18.104.22.168. Overview 22.214.171.124. Immunomodulators Market Forecast and Analysis 7.6. INTERFERONS 7.6.1. Overview 7.6.2. Interferons Market Forecast and Analysis 8. VIROLOGY MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION 8.1. OVERVIEW 8.2. APPLICATION MARKET FORECASTS AND ANALYSIS 8.3. SKIN AND SOFT TISSUE INFECTIONS 8.3.1. Overview 8.3.2. Skin and Soft Tissue Infections Market Forecast and Analysis 8.4. RESPIRATORY TRACT INFECTIONS 8.4.1. Overview 8.4.2. Respiratory Tract Infections Market Forecast and Analysis 8.5. GI TRACT INFECTIONS 8.5.1. Overview 8.5.2. GI Tract Infections Market Forecast and Analysis 8.6. SEXUALLY TRANSMITTED DISEASES 8.6.1. Overview 8.6.2. Sexually Transmitted Diseases Market Forecast and Analysis 8.7. URINARY TRACT INFECTION 8.7.1. Overview 8.7.2. Urinary Tract Infection Market Forecast and Analysis 8.8. OTHERS 8.8.1. Overview 8.8.2. Others Market Forecast and Analysis 9. VIROLOGY MARKET - REVENUE AND FORECASTS TO 2027 - END USER 9.1. OVERVIEW 9.2. END USER MARKET FORECASTS AND ANALYSIS 9.3. HOSPITALS 9.3.1. Overview 9.3.2. Hospitals Market Forecast and Analysis 9.4. DIAGNOSTIC LABORATORIES 9.4.1. Overview 9.4.2. Diagnostic Laboratories Market Forecast and Analysis 9.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES 9.5.1. Overview 9.5.2. Pharmaceutical and Biotechnological Companies Market Forecast and Analysis 9.6. RESEARCH AND ACADEMIC INSTITUTES 9.6.1. Overview 9.6.2. Research and Academic Institutes Market Forecast and Analysis 10. VIROLOGY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS 10.1. NORTH AMERICA 10.1.1 North America Virology Market Overview 10.1.2 North America Virology Market Forecasts and Analysis 10.1.3 North America Virology Market Forecasts and Analysis - By Type 10.1.4 North America Virology Market Forecasts and Analysis - By Application 10.1.5 North America Virology Market Forecasts and Analysis - By End User 10.1.6 North America Virology Market Forecasts and Analysis - By Countries 10.1.6.1 United States Virology Market 10.1.6.1.1 United States Virology Market by Type 10.1.6.1.2 United States Virology Market by Application 10.1.6.1.3 United States Virology Market by End User 10.1.6.2 Canada Virology Market 10.1.6.2.1 Canada Virology Market by Type 10.1.6.2.2 Canada Virology Market by Application 10.1.6.2.3 Canada Virology Market by End User 10.1.6.3 Mexico Virology Market 10.1.6.3.1 Mexico Virology Market by Type 10.1.6.3.2 Mexico Virology Market by Application 10.1.6.3.3 Mexico Virology Market by End User 10.2. EUROPE 10.2.1 Europe Virology Market Overview 10.2.2 Europe Virology Market Forecasts and Analysis 10.2.3 Europe Virology Market Forecasts and Analysis - By Type 10.2.4 Europe Virology Market Forecasts and Analysis - By Application 10.2.5 Europe Virology Market Forecasts and Analysis - By End User 10.2.6 Europe Virology Market Forecasts and Analysis - By Countries 10.2.6.1 Germany Virology Market 10.2.6.1.1 Germany Virology Market by Type 10.2.6.1.2 Germany Virology Market by Application 10.2.6.1.3 Germany Virology Market by End User 10.2.6.2 France Virology Market 10.2.6.2.1 France Virology Market by Type 10.2.6.2.2 France Virology Market by Application 10.2.6.2.3 France Virology Market by End User 10.2.6.3 Italy Virology Market 10.2.6.3.1 Italy Virology Market by Type 10.2.6.3.2 Italy Virology Market by Application 10.2.6.3.3 Italy Virology Market by End User 10.2.6.4 Spain Virology Market 10.2.6.4.1 Spain Virology Market by Type 10.2.6.4.2 Spain Virology Market by Application 10.2.6.4.3 Spain Virology Market by End User 10.2.6.5 United Kingdom Virology Market 10.2.6.5.1 United Kingdom Virology Market by Type 10.2.6.5.2 United Kingdom Virology Market by Application 10.2.6.5.3 United Kingdom Virology Market by End User 10.3. ASIA-PACIFIC 10.3.1 Asia-Pacific Virology Market Overview 10.3.2 Asia-Pacific Virology Market Forecasts and Analysis 10.3.3 Asia-Pacific Virology Market Forecasts and Analysis - By Type 10.3.4 Asia-Pacific Virology Market Forecasts and Analysis - By Application 10.3.5 Asia-Pacific Virology Market Forecasts and Analysis - By End User 10.3.6 Asia-Pacific Virology Market Forecasts and Analysis - By Countries 10.3.6.1 Australia Virology Market 10.3.6.1.1 Australia Virology Market by Type 10.3.6.1.2 Australia Virology Market by Application 10.3.6.1.3 Australia Virology Market by End User 10.3.6.2 China Virology Market 10.3.6.2.1 China Virology Market by Type 10.3.6.2.2 China Virology Market by Application 10.3.6.2.3 China Virology Market by End User 10.3.6.3 India Virology Market 10.3.6.3.1 India Virology Market by Type 10.3.6.3.2 India Virology Market by Application 10.3.6.3.3 India Virology Market by End User 10.3.6.4 Japan Virology Market 10.3.6.4.1 Japan Virology Market by Type 10.3.6.4.2 Japan Virology Market by Application 10.3.6.4.3 Japan Virology Market by End User 10.3.6.5 South Korea Virology Market 10.3.6.5.1 South Korea Virology Market by Type 10.3.6.5.2 South Korea Virology Market by Application 10.3.6.5.3 South Korea Virology Market by End User 10.4. MIDDLE EAST AND AFRICA 10.4.1 Middle East and Africa Virology Market Overview 10.4.2 Middle East and Africa Virology Market Forecasts and Analysis 10.4.3 Middle East and Africa Virology Market Forecasts and Analysis - By Type 10.4.4 Middle East and Africa Virology Market Forecasts and Analysis - By Application 10.4.5 Middle East and Africa Virology Market Forecasts and Analysis - By End User 10.4.6 Middle East and Africa Virology Market Forecasts and Analysis - By Countries 10.4.6.1 South Africa Virology Market 10.4.6.1.1 South Africa Virology Market by Type 10.4.6.1.2 South Africa Virology Market by Application 10.4.6.1.3 South Africa Virology Market by End User 10.4.6.2 Saudi Arabia Virology Market 10.4.6.2.1 Saudi Arabia Virology Market by Type 10.4.6.2.2 Saudi Arabia Virology Market by Application 10.4.6.2.3 Saudi Arabia Virology Market by End User 10.4.6.3 U.A.E Virology Market 10.4.6.3.1 U.A.E Virology Market by Type 10.4.6.3.2 U.A.E Virology Market by Application 10.4.6.3.3 U.A.E Virology Market by End User 10.5. SOUTH AND CENTRAL AMERICA 10.5.1 South and Central America Virology Market Overview 10.5.2 South and Central America Virology Market Forecasts and Analysis 10.5.3 South and Central America Virology Market Forecasts and Analysis - By Type 10.5.4 South and Central America Virology Market Forecasts and Analysis - By Application 10.5.5 South and Central America Virology Market Forecasts and Analysis - By End User 10.5.6 South and Central America Virology Market Forecasts and Analysis - By Countries 10.5.6.1 Brazil Virology Market 10.5.6.1.1 Brazil Virology Market by Type 10.5.6.1.2 Brazil Virology Market by Application 10.5.6.1.3 Brazil Virology Market by End User 10.5.6.2 Argentina Virology Market 10.5.6.2.1 Argentina Virology Market by Type 10.5.6.2.2 Argentina Virology Market by Application 10.5.6.2.3 Argentina Virology Market by End User 11. INDUSTRY LANDSCAPE 11.1. MERGERS AND ACQUISITIONS 11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES 11.3. NEW PRODUCT LAUNCHES 11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS 12. VIROLOGY MARKET, KEY COMPANY PROFILES 12.1. ABBOTT 12.1.1. Key Facts 12.1.2. Business Description 12.1.3. Products and Services 12.1.4. Financial Overview 12.1.5. SWOT Analysis 12.1.6. Key Developments 12.2. JOHNSON AND JOHNSON SERVICES INC. 12.2.1. Key Facts 12.2.2. Business Description 12.2.3. Products and Services 12.2.4. Financial Overview 12.2.5. SWOT Analysis 12.2.6. Key Developments 12.3. F. HOFFMANN-LA ROCHE LTD 12.3.1. Key Facts 12.3.2. Business Description 12.3.3. Products and Services 12.3.4. Financial Overview 12.3.5. SWOT Analysis 12.3.6. Key Developments 12.4. THERMO FISHER SCIENTIFIC INC. 12.4.1. Key Facts 12.4.2. Business Description 12.4.3. Products and Services 12.4.4. Financial Overview 12.4.5. SWOT Analysis 12.4.6. Key Developments 12.5. QIAGEN 12.5.1. Key Facts 12.5.2. Business Description 12.5.3. Products and Services 12.5.4. Financial Overview 12.5.5. SWOT Analysis 12.5.6. Key Developments 12.6. ILLUMINA INC. 12.6.1. Key Facts 12.6.2. Business Description 12.6.3. Products and Services 12.6.4. Financial Overview 12.6.5. SWOT Analysis 12.6.6. Key Developments 12.7. SIEMENS AG 12.7.1. Key Facts 12.7.2. Business Description 12.7.3. Products and Services 12.7.4. Financial Overview 12.7.5. SWOT Analysis 12.7.6. Key Developments 12.8. GLAXOSMITHKLINE PLC 12.8.1. Key Facts 12.8.2. Business Description 12.8.3. Products and Services 12.8.4. Financial Overview 12.8.5. SWOT Analysis 12.8.6. Key Developments 12.9. BOEHRINGER INGELHEIM CORPORATION 12.9.1. Key Facts 12.9.2. Business Description 12.9.3. Products and Services 12.9.4. Financial Overview 12.9.5. SWOT Analysis 12.9.6. Key Developments 12.10. MERCK AND CO. INC 12.10.1. Key Facts 12.10.2. Business Description 12.10.3. Products and Services 12.10.4. Financial Overview 12.10.5. SWOT Analysis 12.10.6. Key Developments 13. APPENDIX 13.1. ABOUT THE INSIGHT PARTNERS 13.2. GLOSSARY OF TERMS
The List of Companies
1. Abbott 2. Johnson and Johnson Services Inc. 3. F. Hoffmann-La Roche Ltd 4. Thermo Fisher Scientific Inc. 5. QIAGEN 6. Illumina Inc. 7. Siemens AG 8. GlaxoSmithKline plc 9. Boehringer Ingelheim Corporation 10. Merck and Co. Inc